Statements (68)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:acquisition |
Shionogi's HIV business
|
| gptkbp:advances |
drives advancements in HIV care
|
| gptkbp:advocacy |
supports patient advocacy groups
advocates for access to HIV treatment |
| gptkbp:awards |
received multiple industry awards
|
| gptkbp:clinical_trial |
invests in clinical research
conducts clinical trials for HIV medications conducts clinical trials in multiple phases shares clinical data with the research community |
| gptkbp:collaboration |
Community organizations
works with academic institutions engages in global collaboration for HIV research partners with governments on health initiatives |
| gptkbp:collaborations |
establishes research partnerships with universities
|
| gptkbp:community_engagement |
engages with communities affected by HIV
|
| gptkbp:community_health |
contributes to global health initiatives
|
| gptkbp:community_programs |
runs community programs for HIV awareness
|
| gptkbp:community_support |
supports HIV awareness campaigns
|
| gptkbp:education |
offers educational resources for healthcare providers
|
| gptkbp:feedback |
incorporates patient feedback into research
|
| gptkbp:financial_support |
provides patient support programs
provides financial support for HIV research |
| gptkbp:focuses_on |
HIV treatment
|
| gptkbp:founded |
gptkb:2009
|
| gptkbp:founder |
gptkb:Glaxo_Smith_Kline
|
| gptkbp:funding |
provides research funding for HIV studies
|
| gptkbp:global_presence |
operates in over 60 countries
|
| gptkbp:has_advisory_board |
has a scientific advisory board
|
| gptkbp:headquarters |
gptkb:Brentford,_United_Kingdom
|
| gptkbp:healthcare |
works to improve healthcare access for marginalized groups
promotes health equity in HIV care |
| gptkbp:healthcare_provider_support |
supports healthcare provider education
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vii V Healthcare
|
| gptkbp:innovation |
focuses on innovative HIV solutions
|
| gptkbp:is_committed_to |
committed to ending the HIV epidemic
|
| gptkbp:leadership |
led by a diverse leadership team
|
| gptkbp:market_position |
strong market presence in HIV treatment
|
| gptkbp:mission |
improving the health of people living with HIV
|
| gptkbp:network |
participates in global health networks
|
| gptkbp:number_of_employees |
over 1,000
|
| gptkbp:parent_company |
gptkb:Glaxo_Smith_Kline
|
| gptkbp:partnership |
gptkb:Global_Fund
gptkb:Pfizer gptkb:UNAIDS gptkb:WHO collaborates with non-profits |
| gptkbp:philanthropy |
engages in philanthropic efforts
|
| gptkbp:product |
gptkb:Cabenuva
gptkb:Dovato gptkb:Juluca gptkb:Triumeq gptkb:Vocabria Apretude |
| gptkbp:provides_guidance_on |
contributes to treatment guidelines for HIV.
works to improve treatment access contributes to clinical guidelines for HIV treatment |
| gptkbp:publications |
publishes scientific research in HIV
|
| gptkbp:regulatory_compliance |
receives regulatory approvals for new drugs
|
| gptkbp:research_focus |
prevention of HIV
long-acting therapies |
| gptkbp:strategy |
develops global strategies for HIV prevention
|
| gptkbp:sustainability_initiatives |
engages in sustainability initiatives
|
| gptkbp:treatment |
aims to improve patient outcomes in HIV treatment
|
| gptkbp:treatment_innovation |
focuses on treatment innovation for HIV
|
| gptkbp:type_of_care |
focuses on patient engagement strategies
|
| gptkbp:bfsParent |
gptkb:GSK
|
| gptkbp:bfsLayer |
4
|